Gavi welcomes U.S. decision to procure 500 million vaccine doses to be delivered through COVAX

Milestones :: Perspectives :: Research

 

Gavi welcomes U.S. decision to procure 500 million vaccine doses to be delivered through COVAX
:: US Government scheme, announced today, will see 500 million doses of the Pfizer-BioNTech vaccine distributed through the COVAX Facility
:: Deliveries will begin in August, with 200 million to be shipped in 2021 and a further 300 million by June 2022
Geneva, 10 June 2021 – Gavi, the Vaccine Alliance, today welcomes the decision by the United States Government to procure 500 million COVID-19 vaccine doses on behalf of the COVAX Facility.
Under the plan, 200 million doses of the Pfizer-BioNTech vaccine will be delivered in 2021, starting in August, with a further 300 million shipped in the first half of 2022.
The doses will be made available to all 92 economies eligible for donor-funded vaccines via the Gavi COVAX Advance Market Commitment (AMC), as well as member states of the African Union.
The 500 million doses outlined in this plan are separate from an earlier decision by the US Government to share 80 million doses starting in June as part of a broader global vaccine sharing strategy